These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 12975258)
1. Polymorphism in glutamate-cysteine ligase modifier subunit gene is associated with impairment of nitric oxide-mediated coronary vasomotor function. Nakamura S; Sugiyama S; Fujioka D; Kawabata K; Ogawa H; Kugiyama K Circulation; 2003 Sep; 108(12):1425-7. PubMed ID: 12975258 [TBL] [Abstract][Full Text] [Related]
2. Polymorphism in the 5'-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction. Nakamura S; Kugiyama K; Sugiyama S; Miyamoto S; Koide S; Fukushima H; Honda O; Yoshimura M; Ogawa H Circulation; 2002 Jun; 105(25):2968-73. PubMed ID: 12081989 [TBL] [Abstract][Full Text] [Related]
3. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Kugiyama K; Doi H; Motoyama T; Soejima H; Misumi K; Kawano H; Nakagawa O; Yoshimura M; Ogawa H; Matsumura T; Sugiyama S; Nakano T; Nakajima K; Yasue H Circulation; 1998 Jun; 97(25):2519-26. PubMed ID: 9657472 [TBL] [Abstract][Full Text] [Related]
4. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. Chu A; Chambers DE; Lin CC; Kuehl WD; Palmer RM; Moncada S; Cobb FR J Clin Invest; 1991 Jun; 87(6):1964-8. PubMed ID: 2040689 [TBL] [Abstract][Full Text] [Related]
5. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis. Shiode N; Morishima N; Nakayama K; Yamagata T; Matsuura H; Kajiyama G J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898 [TBL] [Abstract][Full Text] [Related]
6. Intracoronary infusion of reduced glutathione improves endothelial vasomotor response to acetylcholine in human coronary circulation. Kugiyama K; Ohgushi M; Motoyama T; Hirashima O; Soejima H; Misumi K; Yoshimura M; Ogawa H; Sugiyama S; Yasue H Circulation; 1998 Jun; 97(23):2299-301. PubMed ID: 9639372 [TBL] [Abstract][Full Text] [Related]
7. Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction. Koide S; Kugiyama K; Sugiyama S; Nakamura S; Fukushima H; Honda O; Yoshimura M; Ogawa H J Am Coll Cardiol; 2003 Feb; 41(4):539-45. PubMed ID: 12598062 [TBL] [Abstract][Full Text] [Related]
8. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444 [TBL] [Abstract][Full Text] [Related]
9. A T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene and coronary arterial vasomotility. Yoshimura M; Nakayama M; Shimasaki Y; Ogawa H; Kugiyama K; Nakamura S; Ito T; Mizuno Y; Harada E; Yasue H; Miyamoto Y; Saito Y; Nakao K Am J Cardiol; 2000 Mar; 85(6):710-4. PubMed ID: 12000044 [TBL] [Abstract][Full Text] [Related]
10. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Lefroy DC; Crake T; Uren NG; Davies GJ; Maseri A Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355 [TBL] [Abstract][Full Text] [Related]
11. The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity. Prasad A; Narayanan S; Waclawiw MA; Epstein N; Quyyumi AA J Am Coll Cardiol; 2000 Nov; 36(5):1579-86. PubMed ID: 11079661 [TBL] [Abstract][Full Text] [Related]
13. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia. Fukuda Y; Teragawa H; Matsuda K; Yamagata T; Matsuura H; Chayama K Heart; 2002 Mar; 87(3):264-9. PubMed ID: 11847169 [TBL] [Abstract][Full Text] [Related]
14. Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients. Shiode N; Nakayama K; Morishima N; Yamagata T; Matsuura H; Kajiyama G Am Heart J; 1996 Jun; 131(6):1051-7. PubMed ID: 8644581 [TBL] [Abstract][Full Text] [Related]
15. Vasomotility and nitric oxide bioactivity of the bridging segments of the left anterior descending coronary artery. Shiode N; Kato M; Teragawa H; Yamada T; Hirao H; Nomura K; Sasaki N; Yamagata T; Matsuura H; Kajiyama G Am J Cardiol; 1998 Feb; 81(3):341-3. PubMed ID: 9468080 [TBL] [Abstract][Full Text] [Related]
16. Nitric oxide activity in the atherosclerotic human coronary circulation. Quyyumi AA; Dakak N; Mulcahy D; Andrews NP; Husain S; Panza JA; Cannon RO J Am Coll Cardiol; 1997 Feb; 29(2):308-17. PubMed ID: 9014982 [TBL] [Abstract][Full Text] [Related]
17. Importance of nitric oxide in the coronary artery at rest and during pacing in humans. Nishikawa Y; Ogawa S J Am Coll Cardiol; 1997 Jan; 29(1):85-92. PubMed ID: 8996299 [TBL] [Abstract][Full Text] [Related]
18. Basal and flow-mediated nitric oxide production by atheromatous coronary arteries. Tousoulis D; Tentolouris C; Crake T; Toutouzas P; Davies G J Am Coll Cardiol; 1997 May; 29(6):1256-62. PubMed ID: 9137221 [TBL] [Abstract][Full Text] [Related]